Karim Bitar Sells 132,253 Shares of ConvaTec Group PLC (LON:CTEC) Stock

ConvaTec Group PLC (LON:CTECGet Free Report) insider Karim Bitar sold 132,253 shares of the company’s stock in a transaction that occurred on Friday, March 14th. The stock was sold at an average price of GBX 256 ($3.33), for a total value of £338,567.68 ($440,441.89).

Karim Bitar also recently made the following trade(s):

  • On Monday, March 17th, Karim Bitar sold 436,692 shares of ConvaTec Group stock. The shares were sold at an average price of GBX 256 ($3.33), for a total transaction of £1,117,931.52 ($1,454,314.45).

ConvaTec Group Stock Performance

LON CTEC opened at GBX 257.20 ($3.35) on Thursday. The stock has a market capitalization of £6.54 billion, a price-to-earnings ratio of 43.31, a PEG ratio of 0.93 and a beta of 0.64. The stock has a 50-day moving average of GBX 247.07 and a 200 day moving average of GBX 234.67. The company has a current ratio of 2.26, a quick ratio of 0.96 and a debt-to-equity ratio of 85.32. ConvaTec Group PLC has a twelve month low of GBX 211.80 ($2.76) and a twelve month high of GBX 295.20 ($3.84).

ConvaTec Group Increases Dividend

The firm also recently announced a dividend, which will be paid on Thursday, May 29th. Stockholders of record on Thursday, April 17th will be paid a dividend of $0.05 per share. This represents a dividend yield of 1.36%. This is an increase from ConvaTec Group’s previous dividend of $0.02. The ex-dividend date of this dividend is Thursday, April 17th. ConvaTec Group’s dividend payout ratio is presently 84.20%.

Wall Street Analyst Weigh In

Separately, Berenberg Bank restated a “buy” rating and set a GBX 310 ($4.03) price target on shares of ConvaTec Group in a research report on Wednesday, March 5th.

Check Out Our Latest Analysis on ConvaTec Group

About ConvaTec Group

(Get Free Report)

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.

Featured Stories

Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.